ZA200301030B - Treatment of the insulin resistance syndrome. - Google Patents

Treatment of the insulin resistance syndrome.

Info

Publication number
ZA200301030B
ZA200301030B ZA200301030A ZA200301030A ZA200301030B ZA 200301030 B ZA200301030 B ZA 200301030B ZA 200301030 A ZA200301030 A ZA 200301030A ZA 200301030 A ZA200301030 A ZA 200301030A ZA 200301030 B ZA200301030 B ZA 200301030B
Authority
ZA
South Africa
Prior art keywords
treatment
insulin resistance
resistance syndrome
syndrome
insulin
Prior art date
Application number
ZA200301030A
Inventor
Fryburg David Albert
Gibbs Earl Michael
Koppiker Nandan Parmanand
Original Assignee
Ffizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ffizer Inc filed Critical Ffizer Inc
Publication of ZA200301030B publication Critical patent/ZA200301030B/en

Links

ZA200301030A 2000-08-11 2003-02-06 Treatment of the insulin resistance syndrome. ZA200301030B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22492800P 2000-08-11 2000-08-11

Publications (1)

Publication Number Publication Date
ZA200301030B true ZA200301030B (en) 2004-04-22

Family

ID=33449357

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200301030A ZA200301030B (en) 2000-08-11 2003-02-06 Treatment of the insulin resistance syndrome.

Country Status (1)

Country Link
ZA (1) ZA200301030B (en)

Similar Documents

Publication Publication Date Title
EG23232A (en) Absorbent article.
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
MXPA03001419A (en) Therapeutic combination.
ZA200402688B (en) Method and composition for preventing or reducing the symptons of insulin resistance syndrome.
AP2003002918A0 (en) Pulmonary administration of chemically modified insulin.
ZA200207650B (en) Absorbent structure and absorbent articles containing the absorbent structure.
ZA200110173B (en) Safety syringe.
BR0014930B1 (en) cannula.
MXPA02005950A (en) Chair.
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
MXPA03009167A (en) Absorbent product with improved fit.
EP1459776A4 (en) Syringe
MXPA03009204A (en) Absorbent product with improved fit.
SG116454A1 (en) Absorbent article.
MXPA03006989A (en) Modified leptin with reduced immunogenicity.
ZA200105690B (en) Novel treatment.
PL370272A1 (en) Absorbent structure, and absorbent article containing the absorbent structure
MXPA03007625A (en) Modified thrombopoietin with reduced immunogenicity.
ZA200301030B (en) Treatment of the insulin resistance syndrome.
GB0024093D0 (en) Treatment of the insulin resistance syndrome
GB0030649D0 (en) Treatment of the insulin resistance syndrome
HK1056828A1 (en) Treatment of burns.
GB0128651D0 (en) Syringe
MXPA03008402A (en) Modified insulin with reduced immunogenicity.
GB0106465D0 (en) Treatment of the insulin resistance syndrome